Research Articles
Beyond Interferon Alpha: How Science Is Unlocking a New Arsenal Against Chronic Hepatitis B
Discover how the 13 different interferon subtypes in our bodies may hold the key to more effective, personalized treatments for chronic Hepatitis B.
Targeting the Command Center: How Scientists Are Retraining the Immune System to Fight Crohn's Disease
Explore the groundbreaking CD4 antibody therapy for Crohn's disease - a precision approach that targets specific immune cells rather than broadly suppressing the immune system.
The Gut Microbiome: An Unexpected Key to Boosting CAR-T Therapy
Exploring how the gut microbiome influences CAR-T therapy outcomes and the potential of microbiome modulation to enhance cancer immunotherapy.
Beyond Ruxolitinib: The New Frontier in Conquering Transplant Rejection
Exploring cutting-edge therapies for steroid-refractory acute graft-versus-host disease (SR-aGVHD) beyond ruxolitinib treatment.
Supercharging the Body's Bouncers: The Art of Growing Virus-Fighting T Cells
Learn how scientists optimize culture conditions to expand virus-specific T cells ex vivo for advanced immunotherapies.
Rituximab: The "Vitamin R" Revolution in Medicine
Explore how Rituximab, nicknamed Vitamin R, has transformed treatment for cancer and autoimmune diseases through precision immunotherapy.
The Perfect Storm: When Cancer, COVID-19, and Cardiac Crisis Collide
Exploring the complex intersection of lung cancer immunotherapy, COVID-19 infection, and life-threatening cardiac tamponade through clinical case analysis and diagnostic approaches.
Heat Shock Proteins: Training the Immune System to Fight Cancer and Viral Infections
Explore how CoVal fusion technology uses heat shock proteins to create innovative vaccines against cancer and chronic viral infections.
Theiler's Murine Encephalomyelitis Virus: Nature's Unexpected Gift to Cancer Immunotherapy
Explore how Theiler's Murine Encephalomyelitis Virus (TMEV) is being engineered as a novel vaccine platform for cancer immunotherapy and other therapeutic applications.
T-Cell Tag Team: How a New Combo Therapy Fights Resistant Myeloma
Learn about the promising combination therapy of elranatamab, carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.